Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 58.78B | 63.74B | 43.63B | 40.76B | 37.12B | 30.21B |
Gross Profit | 5.21B | 5.68B | 3.67B | 2.98B | 3.01B | -2.27B |
EBITDA | 4.71B | 4.98B | 3.68B | 2.39B | 3.05B | -7.20B |
Net Income | 743.24M | 766.00M | 632.95M | -1.14B | 513.57M | -8.71B |
Balance Sheet | ||||||
Total Assets | 53.76B | 55.44B | 53.19B | 42.27B | 38.19B | 41.72B |
Cash, Cash Equivalents and Short-Term Investments | 6.85B | 7.68B | 6.21B | 5.54B | 4.86B | 7.10B |
Total Debt | 27.45B | 29.01B | 27.29B | 22.55B | 18.88B | 23.61B |
Total Liabilities | 41.82B | 43.32B | 41.77B | 31.28B | 27.87B | 31.76B |
Stockholders Equity | 11.94B | 12.12B | 11.43B | 10.99B | 10.32B | 9.95B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 315.94M | 2.32B | -1.09B | 2.34B | -7.88B |
Operating Cash Flow | 0.00 | 3.51B | 4.83B | 1.61B | 3.82B | -5.42B |
Investing Cash Flow | 0.00 | -3.16B | -4.52B | -4.24B | -1.42B | -2.93B |
Financing Cash Flow | 0.00 | 1.09B | 436.06M | 3.35B | -4.56B | 9.27B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | ¥48.36B | 6.01 | 5.25% | 15.52% | -4.85% | ||
78 Outperform | ¥25.47B | 15.22 | 0.62% | 24.52% | 38.92% | ||
68 Neutral | ¥22.17B | 8.64 | 5.66% | 0.55% | -24.89% | ||
68 Neutral | ¥28.44B | 14.59 | 1.95% | 10.43% | 38.10% | ||
67 Neutral | ¥6.37B | 11.98 | 1.62% | 0.52% | 34.46% | ||
67 Neutral | ¥19.93B | 26.72 | 1.52% | 46.09% | 24.14% | ||
55 Neutral | AU$3.53B | 16.62 | -1.37% | 3.13% | 4.07% | -17.03% |
Renaissance, Incorporated reported significant financial growth for the fiscal year ended March 31, 2025, with net sales increasing by 46.1% and operating income rising by 54.3% compared to the previous year. The company’s financial position strengthened with an increase in net assets and cash flow, indicating positive operational performance and potential for future growth.